Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-03-12

Clinical Trial Update: Clinical Trial of Simvastatin to Treat Generalized Vitiligo [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating simvastatin as a treatment for generalized vitiligo has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: John Harris | Conditions: Vitiligo | Phase 2 | Status: COMPLETED | Results posted: 2015-03-12